▲ 4.44%
prev close
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest-revenue product, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
Congressional Trades
5
All tracked trades
Members Trading
3
Unique members
Net Activity
-3
1 buys · 4 sells
Members Who Traded This Stock
5 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2025-09-11 | SNYSanofi - American Depositary Shares | Sell | $1,001 - $15,000 | 363d ago | — | |
| 2025-08-04 | SNYSanofi - American Depositary Shares | Buy | $1,001 - $15,000 | 403d ago | — | |
| 2025-07-22 | SNYSanofi - American Depositary Shares | Sell | $1,001 - $15,000 | 433d ago | — | |
| 2024-09-04 | SNYSanofi - American Depositary Shares | Sell | $1,001 - $15,000 | 774d ago | — | |
| 2022-03-16 | SNYSanofi - American Depositary Shares | Sell | $1,001 - $15,000 | 1645d ago | — |
2025-09-11
Lisa McClain
SNY
Amount
$1,001 - $15,000
Filed
363d ago
2025-08-04
Lisa McClain
SNY
Amount
$1,001 - $15,000
Filed
403d ago
2025-07-22
Lisa McClain
SNY
Amount
$1,001 - $15,000
Filed
433d ago
2024-09-04
John James
SNY
Amount
$1,001 - $15,000
Filed
774d ago
2022-03-16
John Rutherford
SNY
Amount
$1,001 - $15,000
Filed
1645d ago
Recent News
Powered by Polygon.io
GSK's New Drugs and Pipeline Hold the Key to Long-Term Growth
Forget Eylea: Regeneron's Real Value May Be Hiding in Its Dupixent Profit Share
Can Nektar's Pipeline Progress Create Long-Term Value Amid Rivalry?
Which Pharma Stock Looks More Attractive: Sanofi or AbbVie?
Matchpoint Therapeutics Expands Leadership Team with Appointment of John O’Malley, M.D., Ph.D., as Chief Medical Officer
Trade Timeline
Congressional activity, newest first
Lisa McClain
2025-09-11 · Sale
$1,001 - $15,000
Lisa McClain
2025-08-04 · Purchase
$1,001 - $15,000
Lisa McClain
2025-07-22 · Sale
$1,001 - $15,000
John James
2024-09-04 · Sale
$1,001 - $15,000
John Rutherford
2022-03-16 · Sale
$1,001 - $15,000